Drugs / DTaP-IPV vero vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00655148 | Sep 2003 → Oct 2006 | — | Statens Serum Institut | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTaP-IPV vero vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00655148 ↗ |
| Known as | DTaP-IPVvero | “A)The investigational vaccine: DTaP-IPV containing IPV produced in a vero-cell line (DTaP-IPVvero)” NCT00655148 ↗ |
| Route | Intramuscular | “DTaP-IPV vero 0.5 mL solution for intramuscular injection” NCT00655148 ↗ |